An herbal supplement is under recall after the U.S. Food and Drug Administration (FDA) identified an undeclared active ingredient typically found in Viagra. The product, known as Primal Herbs Volume, manufactured by Primal Supplements, contains sildenafil, which was not disclosed on the product label. This discovery raises significant health concerns, particularly for individuals who may be taking medications with which sildenafil could interact.
The FDA’s analysis revealed that the presence of sildenafil could pose serious risks to consumers, especially those using nitrates in prescribed medications. Nitrates, commonly prescribed for conditions such as diabetes, high blood pressure, high cholesterol, and heart disease, can interact with sildenafil and potentially lower blood pressure to dangerously low levels. This interaction underscores the importance of transparency in dietary supplements, as undisclosed ingredients can lead to unintended health consequences.
Consumers who purchased Primal Herbs Volume between July 2, 2025, and September 19, 2025, are advised to discontinue use immediately. The company is offering replacements or credit for affected customers. Individuals can find more details regarding the recall on the FDA’s official website.
This incident highlights ongoing concerns regarding the regulation of dietary supplements in the United States. The FDA has been increasing its scrutiny of herbal products to ensure consumer safety, especially as the popularity of such supplements continues to rise. The presence of unlisted pharmaceutical ingredients poses a significant risk, prompting calls for more stringent regulations in the industry.
As consumers become more aware of the potential dangers associated with herbal supplements, it is crucial for manufacturers to prioritize transparency in their labeling practices. The recall of Primal Herbs Volume serves as a reminder to consumers to be vigilant when choosing dietary supplements and to consult healthcare providers regarding their dietary and medicinal interactions.
